Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33718183/

doi: 10.3389/fonc.2021.621992. 1 Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China. 2 Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China. 3 Department of Respiratory Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China. 4 Department of Respiratory Medicine, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.